Rankings
▼
Calendar
AXGN Q2 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q2 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$34M
+51.8% YoY
Gross Profit
$26M
78.9% margin
Operating Income
-$7M
-21.3% margin
Net Income
-$8M
-23.5% margin
EPS (Diluted)
$-0.19
QoQ Revenue Growth
+8.2%
Cash Flow
Operating Cash Flow
-$695,000
Free Cash Flow
-$9M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$211M
Total Liabilities
$92M
Stockholders' Equity
$119M
Cash & Equivalents
$53M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$22M
+51.8%
Gross Profit
$26M
$17M
+60.4%
Operating Income
-$7M
-$8M
+13.3%
Net Income
-$8M
-$8M
+2.6%
← FY 2021
All Quarters
Q3 2021 →